Knowledge Center
Article / Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Source:
Pharma's Almanac, Q4 2016, 23 October 2016
There is growing demand for dry-powder inhalation formulations of drugs to treat both respiratory and systemic diseases. Composite particle technology is allowing the development of more efficient formulations, even for challenging molecules. Spray drying is an enabling technology for composite particle preparation. Formulators must be aware, however, of the tradeoffs between properties that improve aerodynamic performance in the lung but negatively impact process yields or throughputs.
Related links
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2006
Process for the preparation of tamsulosin and intermediates thereof starting from chiral phenylethylamine and using catalytic hydrogenation as the key step
Read more
Scientific Article
/ Jan 01, 2006
Process for preparation of fluticasone analogs via esterification of a carbothioic acid
Read more
Scientific Article